Clinical trials
COVID-19 clinical trials
Below are recruiting covid-19 clinical trials, each written for real people, not researchers. We’re tracking 273 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06631287RecruitingPhase 3
Testing baricitinib for persistent long COVID symptoms
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Tucson, ArizonaAges 18 years+ - NCT07400848Recruiting
Symptoms and recovery after COVID-19 vaccine
This study looks at people who developed new, long-lasting symptoms after a COVID-19 vaccine. It aims to understand their symptoms, do lab tests, and see how they recover over time.
BernAges 18 years+ - NCT07356570Recruiting
Post-COVID care tracking study for long-term symptoms
This study follows people with lasting or complex COVID-19 symptoms who are already in a specialized care program. It aims to better understand and improve recovery after COVID.
Pierre-BéniteAges 18 years+ - NCT06739720RecruitingPhase 2/Phase 3
Test of CP003 for chronic fatigue or long COVID tiredness
This study tests a new supplement called CP003 to see if it helps reduce tiredness in people with chronic fatigue syndrome or long COVID fatigue.
Hong KongAges 40–60 - NCT06792214RecruitingPhase 4
Testing if antivirals prevent long-term heart problems after COVID-19
This study tests whether two antiviral medications, Paxlovid and Veklury (remdesivir), can reduce the risk of long-term heart and blood vessel problems after a COVID-19 infection. It is for adults recently hospitalized with COVID-19 who are not currently on oxygen therapy.
Kingston, OntarioAges 18 years+ - NCT07197138Recruiting
TMS for depression with long COVID
This trial tests whether accelerated TMS (a brain stimulation treatment) can help people with depression who also have long COVID. It may be an option if your depression hasn't improved enough with medication alone.
Munich, BavariaAges 18–65 - NCT06095297Recruiting
Cognitive rehab for brain fog from long COVID
This study tests a computer-based cognitive training program combined with a gentle nerve stimulation device to see if it can improve brain fog and daily functioning in people with long COVID. If you're struggling with thinking, memory, or concentration after COVID, this might help.
Birmingham, AlabamaAges 18 years+ - NCT04983823Recruiting
Study aims to improve long-term heart effects after COVID
This trial looks at how persistent heart-related changes after a past COVID infection may be affected by study treatments. It mainly seeks people who are stable enough for follow-up visits and heart imaging, and who are not already on the specific heart medications required.
Melbourne, VictoriaAges 50–85 - NCT05946512Recruiting
Yoga breathing plus lung MRI measurements for post-COVID symptoms
This study uses breathing exercises from yoga and MRI (a scan of the body) measurements to see how well yoga breathing can improve ongoing breathing symptoms after COVID-19. It also compares results in a few other specific groups and healthy volunteers.
Innsbruck, TyrolAges 18–50 - NCT05293366Recruiting
Long COVID study testing supportive care for multiple body systems
This study looks at people who have recovered from COVID-19 but still deal with long-term problems. It aims to better understand (and potentially help with) ongoing issues that can affect hormones, metabolism, mood, muscles, the heart, lungs, and skin.
NaplesAges 18 years+ - NCT04335773Recruiting
Study of COVID-19 in hospitalized children
This study looks at children (ages 0 to 18) who are in the hospital with suspected COVID-19. It aims to understand what factors affect outcomes and how the immune system responds.
LørenskogAges Up to 18 years - NCT04834869Recruiting
Track safety after COVID-19 vaccination in adults
This study follows adults who have already received a COVID-19 vaccine to monitor side effects and safety over time. Your participation helps researchers understand how the vaccine affects different people who are at higher risk due to their work.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06095284Enrolling by invitation
Antiseizure drug use in nursing homes before and after COVID-19
This study looks at how antiseizure medications are prescribed to long-term nursing home residents and how those prescriptions changed during the COVID-19 pandemic. It helps understand if prescribing patterns affected residents' health.
Richmond, VirginiaAges 21 years+ - NCT07838038Recruiting
COVID-19 vaccine reminder messages for Kaiser Permanente members
This study tests whether different email messages can encourage people to get the updated COVID-19 vaccine. If you join, you'll be part of a Kaiser Permanente program that sends you reminders to help you stay protected.
Pasadena, CaliforniaAges 18 years+ - NCT04445285RecruitingPhase 2
Test drops to thin lung mucus in severe COVID-19
This Phase 2 trial tests rhDNase (a medication similar to Pulmozyme) to improve outcomes and reduce the risk of death in people with severe COVID-19 causing breathing failure. It’s meant for adults who need high-flow oxygen or a breathing machine.
Mobile, AlabamaAges 18 years+ - NCT04558450Recruiting
Study how COVID-19 affects blood vessel stiffness and aging
This study looks at how having COVID-19 may affect your blood vessels over the following months. It may help doctors understand long-term “vascular aging” and who is most at risk, based on how sick you were during your COVID illness.
NancyAges 18 years+ - NCT04586413Recruiting
Help build and study a quality-of-life tool after COVID-19
This study will collect information from adults who had COVID-19 (confirmed by a test or diagnosis) to develop and improve a questionnaire about life after infection. Your answers may help researchers better track symptoms and quality of life over time.
OxfordAges 18 years+ - NCT05061329Recruiting
Learn how the nose’s microbes relate to health and disease
This study explores the tiny living organisms (microbes) in your nose and how they may be linked to health problems. It may help researchers better understand disease triggers and potential new prevention or treatment ideas.
Holstebro, Central JutlandAges 18 years+ - NCT04987957Recruiting
Music therapy to reduce anxiety during COVID-19
This study tests whether listening to music can help lower anxiety levels in people experiencing stress during the COVID-19 pandemic. You may be able to join if you’re a midwife or nurse and can complete online surveys.
BoluAges Any age - NCT04443179Recruiting
Baby brain scans in England to study early development
This study does brain imaging (brain scans) in babies to better understand early brain development and how factors like family history and COVID-19 might relate to development. It may help researchers learn which babies could need extra support later.
LondonAges 16–75 - NCT07795021Recruiting
Stroke care during the COVID-19 pandemic
This study looks at how stroke care was given during the COVID-19 pandemic. It aims to understand if treatments and outcomes changed, which may help improve care for people with stroke in future health emergencies.
PragueAges Any age - NCT07743580RecruitingPhase 3
Secutrelvir for covid-19 patients at high risk
This trial tests a new antiviral pill, secutrelvir, for people with mild to moderate covid-19 who are at higher risk of getting seriously ill. It aims to see if the drug can prevent hospitalization or severe disease.
Coral Gables, FloridaAges 12 years+ - NCT06667063Recruiting
Immune response study for COVID-19 and flu
This study looks at how your immune system responds to COVID-19 or the flu. It may help researchers understand these infections better, whether you are currently sick or healthy.
Wuhan, HubeiAges 18 years+ - NCT07678619Enrolling by invitation
Smart tools for infectious disease decisions
This study tests a smart analysis system to help local health officials make better decisions during infectious disease outbreaks. It aims to see if this tool improves speed and accuracy in responding to diseases like COVID-19, mpox, or flu.
Beijing, Beijing MunicipalityAges 18 years+
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for covid-19?
- Yes. Clin2 currently lists 273 recruiting covid-19 studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a covid-19 trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a covid-19 trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.